
浏览全部资源
扫码关注微信
北京中医药大学东直门医院 北京 100700
罗美,女,在读硕士生
田劭丹,女,博士,主任医师,副教授,博士生导师,主要研究方向:中西医结合防治恶性肿瘤,E-mail:oliviatsd@126.com
收稿日期:2022-11-17,
网络出版日期:2023-02-07,
纸质出版日期:2023-04-30
移动端阅览
罗美, 田劭丹, 侯丽, 等. 319例胰腺癌中医证候分布规律及影响因素分析[J]. 北京中医药大学学报, 2023,46(4):584-592.
LUO Mei, TIAN Shaodan, HOU Li, et al. Analysis of the distribution rules and influencing factors of traditional Chinese medicine syndromes in 319 patients with pancreatic cancer[J]. Journal of beijing university of traditional chinese medicine, 2023, 46(4): 584-592.
罗美, 田劭丹, 侯丽, 等. 319例胰腺癌中医证候分布规律及影响因素分析[J]. 北京中医药大学学报, 2023,46(4):584-592. DOI: 10.3969/j.issn.1006-2157.2023.04.020.
LUO Mei, TIAN Shaodan, HOU Li, et al. Analysis of the distribution rules and influencing factors of traditional Chinese medicine syndromes in 319 patients with pancreatic cancer[J]. Journal of beijing university of traditional chinese medicine, 2023, 46(4): 584-592. DOI: 10.3969/j.issn.1006-2157.2023.04.020.
目的
2
探讨胰腺癌中医证候、症状的分布规律,分析其与患者性别、年龄、病程、病灶部位、临床分期、淋巴结及远处转移情况、既往治疗情况等因素的相关性。
方法
2
回顾性分析319例胰腺癌患者病历资料,进行基本信息及证候统计分析,选择临床常见的6种基本证候(气滞血瘀证、湿热蕴结证、脾虚湿阻证、肝肾阴虚证、气血亏虚证、热毒瘀结证),按照相关中医证候诊断标准进行辨证。描述性统计中医证候及症状分布规律,运用无序多分类logistic回归模型探究证候与性别、年龄、病程、病灶部位、临床分期、淋巴结及远处转移,以及既往治疗情况等的相关性。
结果
2
胰腺癌患者首发症状以腹痛、腹胀较为常见,主要临床症状表现为纳差、乏力、腹痛等。中医证候分布频次从高到低依次是脾虚湿阻证、湿热蕴结证、肝肾阴虚证、气滞血瘀证、气血亏虚证、热毒瘀结证。中医证候在不同性别、年龄、病程、病灶部位,以及是否有淋巴转移、是否接受手术及化学药物治疗(简称“化疗”)等胰腺癌患者中的组间分布差异有统计学意义(
P
<
0.05,
P
<
0.01)。气滞血瘀证与年龄呈正相关,与病程呈负相关;化疗是肝肾阴虚证的危险因素;性别为男性是气血亏虚证的保护因素。
结论
2
胰腺癌患者中脾虚湿阻证和湿热蕴结证较为多见。患者的性别、年龄、病程、病灶部位、是否有淋巴转移、是否接受过化疗等都是中医证候的影响因素。
Objective
2
To investigate the distribution rule of traditional Chinese medicine (TCM) syndromes and symptoms of pancreatic cancer
and to analyze its correlation with various factors
such as gender
age
the course of disease
lesion sites
clinical stage
presence of lymph node or distant metastasis
and previous treatment.
Methods
2
We retrospectively analyzed the medical records of 319 patients with pancreatic cancer. The basic information and syndromes were analyzed. Six common clinical basic syndromes (syndrome of stagnation of qi and blood stasis
syndrome of dampness-heat amassment
syndrome of damp retention due to spleen deficiency
syndrome of yin deficiency of liver and kidney
syndrome of deficiency of both qi and blood
and syndrome of heat-toxin amassment and blood stasis) were selected for syndrome differentiation according to the relevant TCM syndrome diagnosis standards. The distribution rules of TCM syndromes and symptoms were statistically described. A multinomial logistic regression model was used to assess the correlation between TCM syndromes and various factors such as gender
age
the course of disease
lesion sites
clinical stage
lymph node and distant metastasis
and previous treatment.
Results
2
Patients with pancreatic cancer experienced abdominal pain and abdominal distension as the first symptom
and the primary clinical symptoms were anorexia
fatigue
and abdominal pain. The distribution of TCM syndromes from high to low was: syndrome of damp retention due to spleen deficiency
syndrome of dampness-heat amassment
syndrome of yin deficiency of liver and kidney
syndrome of stagnation of qi and blood stasis
syndrome of deficiency of both qi and blood
and syndrome of heat-toxin amassment and blood stasis. The distribution of TCM syndromes in patients with pancreatic cancer with regard to differences in gender
age
disease course
lesion sites
presence of lymphatic metastasis
and surgery or chemotherapy was significantly different (
P
<
0.05
P
<
0.01). Syndrome of qi stagnation and blood stasis was positively associated with age and negatively associated with the course of disease. Chemotherapy was a risk factor for syndrome of yin deficiency of liver and kidney. Male was a protective factor for syndrome of deficiency of both qi and blood.
Conclusion
2
The primary TCM syndromes in patients with pancreatic cancer were syndrome of damp retention due to spleen deficiency and syndrome of dampness-heat amassment. Clinical characteristics
such as gender
age
the course of disease
lesion sites
presence of lymph node metastasis
and chemotherapy were influencing factors for TCM syndromes.
葛均波 , 徐永健 , 王辰 , 等 . 内科学 [M]. 9版 . 北京 : 人民出版社 , 2018 : 439 - 440 .
SUNG H , FERLAY J , SIEGEL RL , et al . Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin , 2021 , 71 ( 3 ): 209 - 249 .
ZHENG R , ZHANG S , ZENG H , et al . Cancer incidence and mortality in China,2016 [J]. J Natl Cancer Cent , 2022 , 2 ( 1 ): 1 - 9 .
RAHIB L , SMITH BD , AIZENBERG R , et al . Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver, and pancreas cancers in the United States [J]. Cancer Res , 2014 , 74 ( 11 ): 2913 - 2921 .
中国抗癌协会胰腺癌专业委员会 . 胰腺癌综合诊治指南(2018版) [J]. 临床肝胆病杂志 , 2018 , 34 ( 10 ): 2109 - 2120 .
ZENG H , CHEN W , ZHNG R , et al . Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries [J]. Lancet Glob Health , 2018 , 6 ( 5 ): 555 - 567 .
陈信义 . 中医药提升肿瘤患者生活质量研究述评 [J]. 北京中医药大学学报 , 2022 , 45 ( 11 ): 1081 - 1088 .
白建平 , 张海波 , 曲鑫 , 等 . 中医治疗胰腺癌思路与方法探讨 [J]. 新中医 , 2010 , 42 ( 8 ): 1 - 2 .
倪泉兴 , 虞先濬 , 刘亮 . 中国胰腺癌临床诊断标准的探讨 [J]. 中国癌症杂志 , 2012 , 22 ( 2 ): 81 - 87 .
中华人民共和国国家卫生健康委员会医政医管局 . 胰腺癌诊疗指南(2022年版) [J]. 中华消化外科杂志 , 2022 , 21 ( 9 ): 1117 - 1136 .
田德禄 . 中医内科学 [M]. 北京 : 人民卫生出版社 , 2002 : 379 - 391 .
林洪生 . 恶性肿瘤中医诊疗指南 [M]. 北京 : 人民卫生出版社 , 2014 : 400 - 416 .
侯丽 , 田劭丹 , 李平 . 中西医结合肿瘤学 [M]. 北京 : 北京科学技术出版社 , 2014 : 61 - 67 .
韩尽斌 , 曹振东 , 刘巧丽 , 等 . 从“胰属脾”谈胰腺癌的病机要素 [J]. 中华中医药学刊 , 2018 , 36 ( 9 ): 2086 - 2088 .
王志刚 , 罗美 , 苗璐 , 等 . 基于中医传承计算平台探析中药治疗胰腺癌用药规律 [J]. 中国医药导报 , 2022 , 19 ( 11 ): 151 - 155 .
王欢 , 金钢 . 胰腺癌精准治疗的现状和展望 [J]. 中国普通外科杂志 , 2021 , 30 ( 9 ): 997 - 1005 .
黄蓉 , 张培彤 , 缪锐 . 基于证候分层诊断模式的223例胰腺癌患者中医证型分布特点回顾性分析 [J]. 中医杂志 , 2022 , 63 ( 6 ): 551 - 556 .
王彤 , 吴承玉 , 杨涛 . 278例胰腺癌证素特征分析 [J]. 中国实验方剂学杂志 , 2016 , 22 ( 12 ): 220 - 223 .
李娜 , 富琦 , 张青 . 郁仁存治疗胰腺癌经验 [J]. 中医杂志 , 2015 , 56 ( 20 ): 1725 - 1727 .
张娟 , 王鹏 , 刘鲁明 . 胰腺癌中医证候分析 [J]. 中华中医药杂志 , 2012 , 27 ( 3 ): 579 - 581 .
刘晓丹 , 高宏 , 唐广义 . 胰腺癌中医辨证分型与预后相关性探索 [J]. 山西中医 , 2018 , 34 ( 10 ): 44 - 46 .
陈卓 , 钱祥 , 张爱琴 , 等 . 基于肠道菌群结构特征研究胰腺癌不同中医证型与预后的相关性 [J]. 浙江中西医结合杂志 , 2019 , 29 ( 12 ): 965 - 969 .
WANG FJ , WANG P , CHEN LY , et al . TAM infiltration differences in “Tumor-First” and “ZHENG-First” models and the underlying inflammatory molecular mechanism in pancreatic cancer [J]. Integr Cancer Ther , 2018 , 17 ( 3 ): 707 - 716 .
王彤 . 胰腺癌辨证规律研究 [D]. 南京 : 南京中医药大学 , 2016 .
JIAO J , CHENG CS , XU P , et al . A mouse model of damp-heat syndrome in traditional Chinese medicine and its impact on pancreatic tumor growth [J/OL]. Front Oncol , 2022 , 12 : 947238 [ 2022-11-02 ]. https://www.frontiersin.org/articles/10.3389/fonc.2022.947238/full https://www.frontiersin.org/articles/10.3389/fonc.2022.947238/full .
0
浏览量
187
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621